If you need more lookups,
subscriptions start at $34 USD/month.
Matthew Dumont Location
Cambridge, MA, US
Matthew Dumont Work
Head of Urology New Business Development (M and A) @ (January 2025 - Present)
Executive Director, Pharmaceutical Strategy and Corporate Development @ (January 2019 - January 2025)
Manager, Global Business Development @ (January 2015 - January 2019)
Corporate Development Analyst @ (January 2013 - December 2015)
Manager, Global Business Development @ (January 2015 - December 2019)
Corporate Development Analyst @ (January 2013 - January 2015)
Global Operations Leadership Development (GOLD) Associate @ (January 2012 - December 2013)
Global Operations Leadership Development (GOLD) Associate @ (January 2012 - January 2013)
Business Technology Analyst @ (January 2011 - January 2012)
Business Technology Analyst @ (January 2011 - December 2012)
Matthew Dumont Education
Columbia Business School
Master of Business Administration - MBA
2017-2019
The Johns Hopkins University
MS/BS (Chemical and Biomolecular Engineering)
2006-2011
Matthew Dumont Skills
Lifesciences
Leadership
Chemical Engineering
Matlab
Data Analysis
Assay Development
Biotechnology
Cell
Business Analysis
Market Research
Process Improvement
Strategic Planning
Strategy
Management Consulting
Microsoft Word
Cancer
Management
Protein Expression
Research
Statistics
Analysis
Process Simulation
Protein Chemistry
Sales
SQL
Engineering
Project Management
Matthew Dumont Summary
Matthew Dumont, based in Cambridge, MA, US, is currently a Head of Urology New Business Development (M and A) at Boston Scientific. Matthew Dumont brings experience from previous roles at Asahi Kasei, Viatris and Catalent Pharma Solutions. Matthew Dumont holds a 2017 - 2019 Master of Business Administration - MBA @ Columbia Business School. With a robust skill set that includes Lifesciences, Leadership, Chemical Engineering, Matlab, Data Analysis and more. Matthew Dumont has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Matthew Dumont?
Find contact details for 700 million professionals.